From: Steroid conversion with CYP106A2 – production of pharmaceutically interesting DHEA metabolites
Steroid | Product formation: main hydroxylation position (minor products if known) | Induction of high-spin shift |
---|---|---|
3-oxo-Δ4 type steroids | ||
Deoxycorticosteronea | 15β | Yes |
6-Fluoric-methyl-deoxycorticosteroneb | 15β | Yes |
Corticosteronea | 15β | No |
Cholestenonec | 15β | Yes |
Progesteronea | 15β (11α, 6β, 9α) | No |
17α-Hydroxyprogesteronea | 15β | No |
20α-Dihydroprogesteronea | 15β | No |
Androstenedionea | 15β | Yes |
Testosteronea | 15β | Yes |
3-hydroxy-Δ5-steroids | ||
Dehydroepiandrosterone† | 7β (7α) | No |
Pregnenolone† | 7β | No |
Stigmasterol† | No | No |
Cholesterol† | No | No |
Other steroids | ||
Estradiol† | No | No |
Estrone† | No | No |
Cis/Trans-androsterone† | No | No |
Digitoxigenin† | n.d | No |
Prednisone† | n.d. | No |
Dexamethasone† | n.d | No |